GPC1 and familial pancreatic carcinoma: Melo et al. showed the presence of proteoglycan glypican-1 (GPC-1) positive EVs in the serum of pancreatic cancer patients, which correlated the level of GPC-1 with the tumor burden and survival of pre- and post-surgical patients, suggesting it as a prognostic marker [322].